HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$8.35
Day range
$7.93 - $8.24
Year range
$2.32 - $15.74
Market cap
543.46M USD
Avg Volume
940.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.28M | -5.69% |
Net income | -20.33M | -22.73% |
Net profit margin | — | — |
Earnings per share | -0.31 | 0.00% |
EBITDA | -22.35M | -17.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 352.31M | 46.17% |
Total assets | 366.28M | 40.49% |
Total liabilities | 17.28M | -2.26% |
Total equity | 349.00M | — |
Shares outstanding | 66.60M | — |
Price to book | 1.59 | — |
Return on assets | -19.52% | — |
Return on capital | -20.23% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.33M | -22.73% |
Cash from operations | -16.80M | -0.22% |
Cash from investing | -1.05M | -146.42% |
Cash from financing | 168.30M | 202,673.49% |
Net change in cash | 150.46M | 1,143.52% |
Free cash flow | -9.53M | 18.53% |
About
Founded
2015
Website
Employees
55
